Hence, we continued to expand the samples and included 40 patients with HbH disease (32 patients—ESA/ αCSα patients, 2 cases—SEA/ αWSα, 5 cases—SEA/-α3.7, an example—SEA/-α4.2) and 58 normal controls without thalassemia. This evidence concerns the gene ACSS2 and thalassemia.